Varzandeh Mohammad, Sabouri Leila, Mansouri Vahid, Gharibshahian Maliheh, Beheshtizadeh Nima, Hamblin Michael R, Rezaei Nima
Department of Materials Engineering Isfahan University of Technology Isfahan Iran.
AmitisGen TECH Dev Group Tehran Iran.
Bioeng Transl Med. 2023 Feb 10;8(3):e10498. doi: 10.1002/btm2.10498. eCollection 2023 May.
Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation-induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano-radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects.
放射增敏剂是能够提高电离辐射杀死细胞效率的化合物或纳米结构。放射增敏作用增加了癌细胞对辐射诱导杀伤的敏感性,同时降低了对周围健康组织细胞结构和功能的潜在损害作用。因此,放射增敏剂是用于提高放射治疗效果的治疗药物。癌症的复杂性和异质性及其病理生理学的多因素性质导致了多种治疗方法。每种方法的有效性在一定程度上已得到证实,但尚未发现根除癌症的确定性治疗方法。本综述讨论了广泛的纳米放射增敏剂,总结了放射增敏纳米粒子与其他几种癌症治疗方案的可能组合,重点介绍了其优缺点、挑战和未来前景。
Bioeng Transl Med. 2023-2-10
Macromol Rapid Commun. 2022-9
Int J Mol Sci. 2019-12-31
Pharmaceutics. 2021-10-21
Crit Rev Oncol Hematol. 2022-1
Oncotarget. 2021-7-6
Indian J Dent Res. 2014
Int J Radiat Biol Relat Stud Phys Chem Med. 1985-11
Nanomaterials (Basel). 2023-10-30
Cancers (Basel). 2022-10-17
Prog Biophys Mol Biol. 2022-11
Biochem Biophys Res Commun. 2022-6-4
Physiol Rep. 2022-3
J Control Release. 2022-5